MK-8745 50mg
50mg
| Purity Not Available
Adooq Bioscience
MK-8745 is a novel Aurora-A specific inhibitor. It induces apoptotic cell death in a p53-dependent manner when tested in vitro in cell lines of multiple lineages.
More Information
Supplier Page
MK-8745 25mg
25mg
| Purity Not Available
Adooq Bioscience
MK-8745 is a novel Aurora-A specific inhibitor. It induces apoptotic cell death in a p53-dependent manner when tested in vitro in cell lines of multiple lineages.
More Information
Supplier Page
Adooq Bioscience
MK-8745 is a novel Aurora-A specific inhibitor. It induces apoptotic cell death in a p53-dependent manner when tested in vitro in cell lines of multiple lineages.
More Information
Supplier Page
MK-8745 10mg
10mg
| Purity Not Available
Adooq Bioscience
MK-8745 is a novel Aurora-A specific inhibitor. It induces apoptotic cell death in a p53-dependent manner when tested in vitro in cell lines of multiple lineages.
More Information
Supplier Page
Adooq Bioscience
Like other tetracyclines, sancycline acts by reversibly binding to the 30S ribosomal subunit and inhibiting protein translation by blocking entry of aminoacyl-tRNA into the ribosome A site.
More Information
Supplier Page
Adooq Bioscience
Like other tetracyclines, sancycline acts by reversibly binding to the 30S ribosomal subunit and inhibiting protein translation by blocking entry of aminoacyl-tRNA into the ribosome A site.
More Information
Supplier Page
Adooq Bioscience
Like other tetracyclines, sancycline acts by reversibly binding to the 30S ribosomal subunit and inhibiting protein translation by blocking entry of aminoacyl-tRNA into the ribosome A site.
More Information
Supplier Page